Dark

Check out our Dark Pool Levels

CLVRW
CLEVER LEAVES HLDGS WTS
stock OTC

Inactive

Dec 12, 2025

0.000100USD0.000%(0.000000)171,609

Pre-market

0.00USD-100.000%(0.00)0

After-hours

0.00USD0.000%(0.00)0

Overview HistoricalExchangesShortsNews

Jan 26, 2022

08:30AM EST Clever Leaves Enters US Consumer CBD Market GlobeNewswire Inc

Jan 7, 2022

08:30AM EST Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (Clever Leaves or the Company), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the 2022 ICR Conference, which is being held virtually from January 10-12, 2022. GlobeNewswire Inc

Dec 21, 2021

10:01AM EST Clever Leaves Licensed Expansion Doubles GlobeNewswire Inc

Nov 23, 2021

08:30AM EST Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) (Clever Leaves or the Company), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor conferences in November and December 2021: GlobeNewswire Inc

Nov 10, 2021

09:45PM EST Clever Leaves Reports Third Quarter 2021 Results, Continues Expansion Benzinga

Oct 27, 2021

08:30AM EDT Clever Leaves to Hold Third Quarter 2021 Conference Call GlobeNewswire Inc

Oct 19, 2021

08:30AM EDT Clever Leaves Announces Partnership with Colombian-based Pharmalab GlobeNewswire Inc

Oct 6, 2021

08:30AM EDT Clever Leaves Exports Its First Commercial Shipment of THC Flower GlobeNewswire Inc

Oct 4, 2021

12:43PM EDT Clever Leaves Holdings Inc. (Nasdaq: CLVR) (Clever Leaves or the Company), a leading multinational operator and licensed producer of pharmaceutical-grade cannabinoids, is scheduled to participate in the following investor events in October 2021: GlobeNewswire Inc

Aug 12, 2021

04:05PM EDT - Q2 2021 Revenue Increased 89% and Gross Profit Increased 157% Year-Over-Year - GlobeNewswire Inc

Aug 11, 2021

08:00AM EDT This project will be one of the first sponsored research partnerships under Clever Leaves recently announced Project Change Lives Campaign, whereby the Company has pledged to contribute up to US $25 million retail value of medical cannabis products to any eligible U.S. organization in order to help advance scientific research into the medical benefits of cannabinoids. GlobeNewswire Inc

Aug 2, 2021

04:05PM EDT Clever Leaves to Hold Second Quarter 2021 Conference Call on GlobeNewswire Inc

Dec 18, 2020

08:00AM EST Schultze Special Purpose Acquisition Corp. and Clever Leaves GlobeNewswire Inc

Share